Molecular Mechanisms of Drug Resistance in Glioblastoma

Glioblastoma multiforme (GBM) is the most common and fatal primary brain tumor, is highly resistant to conventional radiation and chemotherapy, and is not amenable to effective surgical resection. The present review summarizes recent advances in our understanding of the molecular mechanisms of thera...

Full description

Bibliographic Details
Main Authors: Maya A. Dymova, Elena V. Kuligina, Vladimir A. Richter
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/12/6385
_version_ 1797530117372641280
author Maya A. Dymova
Elena V. Kuligina
Vladimir A. Richter
author_facet Maya A. Dymova
Elena V. Kuligina
Vladimir A. Richter
author_sort Maya A. Dymova
collection DOAJ
description Glioblastoma multiforme (GBM) is the most common and fatal primary brain tumor, is highly resistant to conventional radiation and chemotherapy, and is not amenable to effective surgical resection. The present review summarizes recent advances in our understanding of the molecular mechanisms of therapeutic resistance of GBM to already known drugs, the molecular characteristics of glioblastoma cells, and the barriers in the brain that underlie drug resistance. We also discuss the progress that has been made in the development of new targeted drugs for glioblastoma, as well as advances in drug delivery across the blood–brain barrier (BBB) and blood–brain tumor barrier (BBTB).
first_indexed 2024-03-10T10:24:22Z
format Article
id doaj.art-5a908876ae054385aa31fb6372a3232d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T10:24:22Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-5a908876ae054385aa31fb6372a3232d2023-11-22T00:09:33ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-06-012212638510.3390/ijms22126385Molecular Mechanisms of Drug Resistance in GlioblastomaMaya A. Dymova0Elena V. Kuligina1Vladimir A. Richter2The Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, RussiaThe Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, RussiaThe Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, RussiaGlioblastoma multiforme (GBM) is the most common and fatal primary brain tumor, is highly resistant to conventional radiation and chemotherapy, and is not amenable to effective surgical resection. The present review summarizes recent advances in our understanding of the molecular mechanisms of therapeutic resistance of GBM to already known drugs, the molecular characteristics of glioblastoma cells, and the barriers in the brain that underlie drug resistance. We also discuss the progress that has been made in the development of new targeted drugs for glioblastoma, as well as advances in drug delivery across the blood–brain barrier (BBB) and blood–brain tumor barrier (BBTB).https://www.mdpi.com/1422-0067/22/12/6385glioblastoma multiformedrug resistancemolecular mechanism
spellingShingle Maya A. Dymova
Elena V. Kuligina
Vladimir A. Richter
Molecular Mechanisms of Drug Resistance in Glioblastoma
International Journal of Molecular Sciences
glioblastoma multiforme
drug resistance
molecular mechanism
title Molecular Mechanisms of Drug Resistance in Glioblastoma
title_full Molecular Mechanisms of Drug Resistance in Glioblastoma
title_fullStr Molecular Mechanisms of Drug Resistance in Glioblastoma
title_full_unstemmed Molecular Mechanisms of Drug Resistance in Glioblastoma
title_short Molecular Mechanisms of Drug Resistance in Glioblastoma
title_sort molecular mechanisms of drug resistance in glioblastoma
topic glioblastoma multiforme
drug resistance
molecular mechanism
url https://www.mdpi.com/1422-0067/22/12/6385
work_keys_str_mv AT mayaadymova molecularmechanismsofdrugresistanceinglioblastoma
AT elenavkuligina molecularmechanismsofdrugresistanceinglioblastoma
AT vladimirarichter molecularmechanismsofdrugresistanceinglioblastoma